Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer Supplemental figure 1

Bristol Myers Squibb sponsored this study and provided financial support for the conduct of the research and preparation of the article. C Doran and L Lal are employees of ConcertAI and report research funding to their institution from Bristol Myers Squibb. Y Zhang, K Le, B Dreyfus, N Kola, B Sylvester, J Penrod and S Meadows Shropshire are employed by Bristol Myers Squibb and hold stock or stock options.